⠀
📊 𝐑𝐞𝐬𝐮𝐥𝐭𝐬
• Revenue: $6.13B (+1.0% YoY)
• Revenue Excluding Excise Taxes: $5.44B (+3.6% YoY)
• GAAP EPS: $1.51 (+7.1% YoY)
• Adj. EPS: $1.52 (+4.8% YoY)
• Smokeable Products Adj. Operating Income: $3.07B (+3.9% YoY)
• Oral Tobacco Adj. Operating Income: $443M (-3.7% YoY)
⠀
🎯 𝐆𝐮𝐢𝐝𝐚𝐧𝐜𝐞 (𝐅𝐘𝟐𝟔)
• Adj. EPS: $5.66–$5.74 (+4.5% to +6.0% YoY), raised
• Dividend Growth Target: Mid-single digits annually through 2028
⠀
📌 𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬
• Cigarette shipment volume -2.9% YoY; -4% adjusted for inventory movements
• Marlboro shipments -6.4%; discount cigarette shipments +40.5%
• Smokeable Products adjusted operating margin reached 64.5%
• Oral tobacco shipment volume -4.3%; on! shipments +13.3%
• on! nicotine pouch category share declined 130 bps to 13.5%
• Board authorized an additional $1B in share repurchases
• Repurchased $400M in shares during Q3
• Paid $1.7B in quarterly dividends; annualized dividend $4.44/share
⠀
💬 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲
“Our strong performance through the first nine months and confidence in our full-year plan allowed us to raise our earnings guidance for the year.” — CEO Sal Mancuso

